In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...

A new U.N. AIDS agency report says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global effort ...

In a report released on Thursday, the UN body in charge of fighting HIV/Aids does not single out the US, but says that ...

If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...

Lenacapavir is available in both oral tablet form and as subcutaneous injections. It is available as oral tablets and ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

UN says if US funding for HIV programs is not replaced, millions more will die by 2029 ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

Strategies that address population-specific concerns about medical mistrust and employ operational tactics, including staff ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

People living with HIV face unique oral health challenges that require special attention and care. The virus's impact on the ...

Significant demographic differences were found when evaluating the use of depression services in people living with HIV and depression.